| | | OMB APPROVAL |
| | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB Number: 3235-0167 Expires: November 30, 2010 Estimated average burden hours per response . . . . . 1.50 |
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 000-52836
Dr. Tattoff, Inc.
(Exact name of registrant as specified in its charter)
8500 Wilshire Boulevard, Suite 105, Beverly Hills, California 90211 (310) 659-5101
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common stock, $.0001 par value
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) Rule 12g-4(a)(2) Rule 12h-3(b)( 1 )(i) Rule 12h-3(b)(1)(ii) Rule 15d-6 | x o o o o |
Approximate number of holders of record as of the certification or notice date: 101
Pursuant to the requirements of the Securities Exchange Act of 1934, Dr. Tattoff, Inc., has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: March 16, 2010 | By: | /s/ Mark Edwards | |
| | Mark Edwards, Chief Financial Officer | |
| | | | |
